Marie-Luise Berres
Marie-Luise Berres
Uniklinikum Aachen
Verified email at
Cited by
Cited by
Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility
PA Muller, B Koscsˇ, GM Rajani, K Stevanovic, ML Berres, D Hashimoto, ...
Cell 158 (2), 300-313, 2014
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
ML Berres, KPH Lim, T Peters, J Price, H Takizawa, H Salmon, J Idoyaga, ...
Journal of Experimental Medicine 211 (4), 669-683, 2014
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis
R Chakraborty, OA Hampton, X Shen, SJ Simko, A Shih, H Abhyankar, ...
Blood, The Journal of the American Society of Hematology 124 (19), 3007-3015, 2014
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
ML Berres, RR Koenen, A Rueland, MM Zaldivar, D Heinrichs, H Sahin, ...
The Journal of clinical investigation 120 (11), 4129-4140, 2010
Dietary intake regulates the circulating inflammatory monocyte pool
S Jordan, N Tung, M Casanova-Acebes, C Chang, C Cantoni, D Zhang, ...
Cell 178 (5), 1102-1114. e17, 2019
Inhibition of hepatic fibrogenesis by matrix metalloproteinase‐9 mutants in mice
M Roderfeld, R Weiskirchen, S Wagner, ML Berres, C Henkel, ...
the FASEB Journal 20 (3), 444-454, 2006
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans
HE Wasmuth, F Lammert, MM Zaldivar, R Weiskirchen, C Hellerbrand, ...
Gastroenterology 137 (1), 309-319. e3, 2009
CXC chemokine ligand 4 (Cxcl4) is a platelet‐derived mediator of experimental liver fibrosis
MM Zaldivar, K Pauels, P von Hundelshausen, ML Berres, P Schmitz, ...
Hepatology 51 (4), 1345-1353, 2010
Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
ML Berres, M Merad, CE Allen
British journal of haematology 169 (1), 3-13, 2015
Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74
D Heinrichs, M Knauel, C Offermanns, ML Berres, A Nellen, L Leng, ...
Proceedings of the National Academy of Sciences 108 (42), 17444-17449, 2011
Chemokine Cxcl9 attenuates liver fibrosis‐associated angiogenesis in mice
H Sahin, E Borkham‐Kamphorst, C Kuppe, MM Zaldivar, C Grouls, ...
Hepatology 55 (5), 1610-1619, 2012
Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap
YA Lee, LA Noon, KM Akat, MD Ybanez, TF Lee, ML Berres, N Fujiwara, ...
Nature communications 9 (1), 1-12, 2018
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection
ML Berres, S Papen, K Pauels, P Schmitz, MM Zaldivar, C Hellerbrand, ...
Journal of hepatology 50 (2), 370-376, 2009
Longitudinal monocyte human leukocyte antigen‐DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis
ML Berres, B Schnyder, E Yagmur, B Inglis, S Stanzel, JJW Tischendorf, ...
Liver International 29 (4), 536-543, 2009
Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases
ML Berres, CE Allen, M Merad
Advances in immunology 120, 127-161, 2013
Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases
F Tacke, HW Zimmermann, ML Berres, C Trautwein, HE Wasmuth
Liver International 31 (6), 840-849, 2011
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection
ML Berres, C Trautwein, M Schmeding, D Eurich, F Tacke, M Bahra, ...
Hepatology 53 (2), 596-603, 2011
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection
HE Wasmuth, MM Zaldivar, ML Berres, A Werth, D Scholten, S Hillebrandt, ...
Journal of hepatology 48 (2), 208-215, 2008
Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes
H Sahin, E Borkham‐Kamphorst, NT do O, ML Berres, M Kaldenbach, ...
Hepatology 57 (2), 797-805, 2013
Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis
C Henkel, M Roderfeld, R Weiskirchen, ML Berres, S Hillebrandt, ...
Proteomics 6 (24), 6538-6548, 2006
The system can't perform the operation now. Try again later.
Articles 1–20